These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15918335

  • 1. Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.
    Kim HS, Han KH, Ahn SH, Kim EO, Chang HY, Moon MS, Chung HJ, Yoo W, Kim SO, Hong SP.
    Antivir Ther; 2005; 10(3):441-9. PubMed ID: 15918335
    [Abstract] [Full Text] [Related]

  • 2. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
    Woo HY, Park H, Kim BI, Jeon WK, Cho YK, Kim YJ.
    Antivir Ther; 2007; 12(1):7-13. PubMed ID: 17503742
    [Abstract] [Full Text] [Related]

  • 3. Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough.
    Lee CH, Kim SO, Byun KS, Moon MS, Kim EO, Yeon JE, Yoo W, Hong SP.
    Gastroenterology; 2006 Apr; 130(4):1144-52. PubMed ID: 16618409
    [Abstract] [Full Text] [Related]

  • 4. Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy.
    Ding C, Wong VW, Chow KC, Chan HY, Hui AY, Wong GL, Lo YM, Sung JJ, Chan HL.
    Antivir Ther; 2006 Apr; 11(8):1041-9. PubMed ID: 17302374
    [Abstract] [Full Text] [Related]

  • 5. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments.
    Hong SP, Kim NK, Hwang SG, Chung HJ, Kim S, Han JH, Kim HT, Rim KS, Kang MS, Yoo W, Kim SO.
    J Hepatol; 2004 May; 40(5):837-44. PubMed ID: 15094233
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of dual priming oligonucleotide-based multiplex PCR for detection of HBV YMDD mutants.
    Woo HY, Park H, Kim BI, Jeon WK, Kim YJ.
    Arch Virol; 2008 May; 153(11):2019-25. PubMed ID: 18836856
    [Abstract] [Full Text] [Related]

  • 8. Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions.
    Aberle SW, Kletzmayr J, Watschinger B, Schmied B, Vetter N, Puchhammer-Stöckl E.
    J Clin Microbiol; 2001 May; 39(5):1972-4. PubMed ID: 11326026
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance].
    Hu YY, Jiang JJ, Li D, Lin CW, Li QG, Chen Y.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):427-30. PubMed ID: 12890350
    [Abstract] [Full Text] [Related]

  • 11. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM.
    Antivir Ther; 2006 Jul; 11(4):447-55. PubMed ID: 16856618
    [Abstract] [Full Text] [Related]

  • 12. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
    Ağca H, Sayıner AA, Sengönül A, Simşek I, Akarsu M.
    Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
    [Abstract] [Full Text] [Related]

  • 13. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay.
    Roque-Afonso AM, Férey MP, Mackiewicz V, Fki L, Dussaix E.
    Antivir Ther; 2003 Dec; 8(6):627-34. PubMed ID: 14760897
    [Abstract] [Full Text] [Related]

  • 14. Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.
    Cheong JY, Cho SW, Yoo JH, Hong SP, Kim SO, Yoo WD, Kim JH.
    Hepatogastroenterology; 2008 Dec; 55(84):1029-33. PubMed ID: 18705323
    [Abstract] [Full Text] [Related]

  • 15. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [Abstract] [Full Text] [Related]

  • 16. Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine.
    Xu G, You Q, Pickerill S, Zhong H, Wang H, Shi J, Luo Y, You P, Kong H, Lu F, Hu L.
    J Med Virol; 2010 Jul; 82(7):1143-9. PubMed ID: 20513076
    [Abstract] [Full Text] [Related]

  • 17. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
    Selabe SG, Song E, Burnett RJ, Mphahlele MJ.
    J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
    [Abstract] [Full Text] [Related]

  • 18. Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
    Alvarado-Esquivel C, de la Ascensión Carrera-Gracia M, Conde-González CJ, Juárez-Figueroa L, Ruiz-Maya L, Aguilar-Benavides S, Torres-Valenzuela A, Sablon E.
    J Antimicrob Chemother; 2006 Feb; 57(2):221-3. PubMed ID: 16373428
    [Abstract] [Full Text] [Related]

  • 19. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
    Ogata N, Ichida T, Aoyagi Y, Kitajima I.
    Rinsho Byori; 2003 Apr; 51(4):313-9. PubMed ID: 12747252
    [Abstract] [Full Text] [Related]

  • 20. Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.
    Shi M, Yang ZJ, Wang RS, Zhang H, Zhu YF, Xu YP, Lin QY, Jin LJ.
    Clin Chim Acta; 2006 Nov; 373(1-2):172-5. PubMed ID: 16814763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.